• Career
  • Support
  • Contact Us
Menu
  • Career
  • Support
  • Contact Us
  • Solutions
    • Medical Device Services
    • Medical Research Services
  • Get Started
    • Get Set Up
    • Get a Quote
  • Science
    • What We Do
    • How We Do It
    • Why It Matters
    • Our Core Areas
    • Technology
  • News & Events
    • News
    • Events
  • Resources
    • Webinars
    • Publications
    • Whitepapers
    • Report References
    • Media
  • About Us
    • About AMRA
    • The Team
    • Partners & Investors
Menu
  • Solutions
    • Medical Device Services
    • Medical Research Services
  • Get Started
    • Get Set Up
    • Get a Quote
  • Science
    • What We Do
    • How We Do It
    • Why It Matters
    • Our Core Areas
    • Technology
  • News & Events
    • News
    • Events
  • Resources
    • Webinars
    • Publications
    • Whitepapers
    • Report References
    • Media
  • About Us
    • About AMRA
    • The Team
    • Partners & Investors
Search
Close
Menu
  • Solutions
    • Medical Device Services
    • Medical Research Services
  • Get Started
    • Get a Quote
    • Get Set Up
  • News & Events
    • News
    • Events
  • Science
    • What We Do
    • How We Do It
    • Why It Matters
    • Our Core Areas
    • Technology
  • Resources
    • Webinars
    • Publications
    • Whitepapers
    • Report References
    • Media
  • About Us
    • About AMRA
    • The Team
    • Partners & Investors
  • Career
  • Support
  • Contact Us
  • All Webinars

Whole-body MRI in FSH Muscular Dystrophy Research

  • The recorded webinar will soon be uploaded. Please come back in a couple of days.

Within the framework of FSHD University, AMRA’s SVP Global Development and Marketing Rosemary Shull presented at the webinar “Whole-body MRI in FSH muscular dystrophy research”.

The gist of the webinar as described by FSHD Society:

We refer often to MRI (magnetic resonance imaging) as an almost magical way to peer inside the body and see what’s going on with our muscles. MRI is a key component of Fulcrum’s ReDUX4 clinical trial for FSH muscular dystrophy. But do you really understand how this technology works, and what it can and can’t reveal? Is it useful only for research, or does it have a place in healthcare for FSHD? At this month’s webinar, Rosemary Shull of AMRA, the Swedish company that is working with Fulcrum, will explain how MRI works and the role it is playing in the ReDUX4 trial. She’ll be sharing some stunning images that are enabling researchers to visualize what is going on with FSHD as never before.

 

Share on twitter
Share on linkedin
Share on facebook
Share on email
Webinar Date
  • 21 January 2021
What you will learn
•
How magnetic resonance imaging technology works
•
MRI experience for the participant
•
What MRI can reveal and its limitations
•
Place of MRI in FSHD research
•
Visualize what is going on with FSHD
Who should attend?
•
Members of the FSHD community
•
Trial participants interested in MRI
•
Research Nurse
•
Principal Investigator
•
Clinical Project Manager
•
Clinical Development Manager
•
Business Development
•
Clinical Operations

AMRA Medical is a digital health company at the forefront of medical imaging and precision medicine. The company has developed a new global standard in body composition analysis, delivering multiple fat and muscle biomarkers with unrivaled accuracy and precision – all from a rapid whole-body MRI scan.

AMRA offers medical device and medical research services to support transformative care and vital decision-making, from clinical research to clinical care.

Contact

  • info@amramedical.com
  • +46 (0) 13 16 26 00
  • Contact Our Support
Follow us
Linkedin Twitter Facebook

Newsletter

    • Data Privacy Policy
    • Cookies
    Menu
    • Data Privacy Policy
    • Cookies

    © 2022 AMRA Medical AB

    By using our site, you acknowledge that you have read and understood our privacy policy. We use cookies to ensure you have the best browsing experience on our website.
    Accept & Close